In celebration of the tenth anniversary of the EAPCI PCR Fellows Course, Gabor Toth interviews Chiara De Biase about the initial target participants of the Course, the topics covered during this one-day event, and the decision to exclude structural topics to promote the PCR London Valves...

Euro4C, which stands for Contemporary Care of patients with Calcified Complex lesions, addresses the increasing challenges posed by an aging population. Its mission is to enhance clinical outcomes for patients with advanced, diffuse, and calcified atherosclerotic CAD, particularly those presenting with critical conditions and left ventricular dysfunction.

Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.

True to its core mission of serving the needs of each individual patient by helping the cardiovascular community share knowledge experience and practice, PCR has been welcoming and supporting communities’ initiatives all throughout its history + mot du president ...

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Yohei Ohno provides his takeaways from the results of the MATTERHORN trial presented by Volker Rudolph at the ESC Congress 2024 in London.

This case report demonstrates, for the first time, the feasibility of mitral TEER with a robotic-assisted approach, using the Abbott MitraClip G4 system, potentially paving the way for future applications in structural heart and endovascular interventions.

Alex Sticchi provides his take on the results of the TRI.FR trial presented by Erwan Donal at the ESC Congress 2024 in London.

Elad Asher provides his take on the ASSURE DES trial presented by Jung-Min Ahn at the ESC Congress 2024 in London.

Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.

Who better to recount its history than the inaugural President of the Euro4C Group? Additionally, insights are provided by the Chairman of PCR, the former EAPCI President, and a pivotal member of the editorial team.

Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.

While Chiara De Biase interviews Helene Eltchaninoff about the RHEIA trial results, which she presented at the ESC Congress 2024 in London, Panos Xaplanteris shares his perspective on the trial, offering all the essential information and key takeaways you need for your practice!

Julia Grapsa provides her take on the Chronic Coronary Syndromes (CCS) Guidelines which were presented by Felicita Andreotti and Christiaan Vrints at ESC Congress 2024 in London.

Mirvat Alasnag provides her take on the SENIOR-RITA trial, presented by Vijay Kunadian at the ESC Congress 2024 in London.

Aaysha Cader interviews Gianluca Campo about the EARTH-STEMI trial he presented at ESC Congress 2024 in London.

This meta-analysis aimed to evaluate a large cohort of STEMI patients, predominantly comorbid, with a mean age of 79 and extended long-term follow-up. The key findings revealed that complete revascularisation reduced the...

Aaysha Cader interviews David Ferreira about the SCOFF trial he presented at the ESC Congress 2024 in London.

Results showed that eating normally before minimally invasive heart procedures did not increase complications and improved patient satisfaction, suggesting a need to reconsider fasting guidelines.

Alex Sticchi provides his take on the OCCUPI trial presented by Kim Byeong-Keuk at the ESC Congress 2024 in London.

Discover the individuals driving the Euro4C Group, including the main board, national coordinators, research and education groups, and the dedicated editorial team!

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.